Get the Stockscreener App
76.19
0.41%
-0.31
After Hours:
76.19
Henry Schein Inc stock is traded at $76.19, with a volume of 510.47K.
It is down -0.41% in the last 24 hours and up +2.32% over the past month.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
See More
Previous Close:
$76.50
Open:
$76.2
24h Volume:
510.47K
Relative Volume:
0.36
Market Cap:
$8.97B
Revenue:
$12.50B
Net Income/Loss:
$314.00M
P/E Ratio:
31.23
EPS:
2.44
Net Cash Flow:
$421.00M
1W Performance:
-0.55%
1M Performance:
+2.32%
6M Performance:
+4.83%
1Y Performance:
+8.83%
1-Day Range:
$75.85
$76.78
1-Week Range:
$75.85
$78.10
52-Week Range:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
76.19 | 9.01B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
826.43 | 101.92B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
339.98 | 66.07B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
CAH
Cardinal Health Inc
|
207.54 | 49.27B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
AHG
Akso Health Group Adr
|
1.41 | 743.84M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Aug-26-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-25-25 | Downgrade | Stifel | Buy → Hold |
| Jul-14-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
| Jan-06-25 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
Henry Schein, Inc. $HSIC Shares Purchased by Swedbank AB - MarketBeat
Henry Schein Board Advances CEO Succession and Transition - The Globe and Mail
How is Henry Schein's stock performance compared to other healthcare stocks? - MSN
Henry Schein expects to name new CEO by mid-January 2026 - Investing.com Nigeria
Henry Schein (HSIC) to Appoint New CEO by January 2026 - GuruFocus
Henry Schein Says it Expects to Name Next CEO by Mid-January 2026 - marketscreener.com
Henry Schein expects to appoint next CEO by mid-January (HSIC:NASDAQ) - Seeking Alpha
Henry Schein Provides Update on CEO Search Process - The Joplin Globe
Henry Schein (HSIC) Extends Private Placement Shelf Facilities - GuruFocus
Henry Schein amends private shelf agreements to extend termination dates By Investing.com - Investing.com Nigeria
Henry Schein Extends Private Placement Facilities to 2028 - TipRanks
Henry Schein amends private shelf agreements to extend termination dates - Investing.com
Henry Schein amends private shelf agreement with PGIMSEC filing - marketscreener.com
Henry ScheinOn Dec 19, Amends Private Shelf Agreement With PGIMSEC Filing - TradingView — Track All Markets
Henry Schein Updates Multiple Financing Agreements With Major Lenders - TradingView — Track All Markets
Berger Financial Group Inc Invests $2.98 Million in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein (HSIC): Revisiting Valuation After Q3 2025 Earnings Beat and Upgraded Guidance - Sahm
Can Henry Schein Inc. stock maintain growth trajectoryWeekly Stock Recap & Smart Money Movement Tracker - Улправда
Thrivent Financial for Lutherans Has $4.97 Million Position in Henry Schein, Inc. $HSIC - MarketBeat
Why Henry Schein Inc. stock remains undervalued2025 Bull vs Bear & Safe Capital Growth Stock Tips - ulpravda.ru
Henry Schein One Drives Dentrix Ascend Growth - Dentistry Today
Can Henry Schein Inc. stock surprise with earnings upside2025 Fundamental Recap & Daily Chart Pattern Signals - DonanımHaber
Is Henry Schein Inc. stock recession proofWeekly Trade Recap & Free Risk Controlled Daily Trade Plans - DonanımHaber
Will Henry Schein Inc. stock attract ESG investors2025 Macro Impact & Weekly High Return Stock Forecasts - DonanımHaber
Is Henry Schein Inc. stock a safe haven assetWeekly Investment Summary & High Accuracy Investment Entry Signals - Улправда
Highlights and insights from Henry Schein’s new report predicting 2026 dental data - Dental Economics
DentScribe Joins Henry Schein One Exchange - Dentistry Today
Palmetto Grain Brokerage - Palmetto Grain Brokerage
How Is Henry Schein's Stock Performance Compared to Other Healthcare Stocks? - Barchart.com
DentScribe Joins Henry Schein One API Exchange as an Authorized Integration Vendor - StreetInsider
Traverse City Topic HENRY SCHEIN, INC. | News, Weather, Sports, Breaking News - WPBN
Squarepoint Ops LLC Boosts Holdings in Henry Schein, Inc. $HSIC - MarketBeat
Top 2 Health Care Stocks That May Keep You Up At Night In December - Benzinga
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein, Inc.'s (NASDAQ:HSIC) Shareholders Might Be Looking For Exit - 富途牛牛
Westwood Holdings Group Inc. Invests $20.63 Million in Henry Schein, Inc. $HSIC - MarketBeat
Is Henry Schein Inc a good long term investmentHealthcare Stock Analysis & High Return Trading Strategies - earlytimes.in
Robert I. Schattner Oral Health Center for People with Disabilities established at Hebrew University-Hadassah School of Dental Medicine - EurekAlert!
Thompson Davis & CO. Inc. Buys Shares of 17,270 Henry Schein, Inc. $HSIC - MarketBeat
Loss Report: Will Henry Schein Inc stock benefit from infrastructure spendingOptions Play & Real-Time Sentiment Analysis - moha.gov.vn
Revenue per share of Henry Schein, Inc. – FWB:HS2 - TradingView — Track All Markets
Jim Cramer on Henry Schein: “I Think It’s a Good Stock” - MSN
Do Wall Street Analysts Like Henry Schein Stock? - MSN
Ilex Capital Partners UK LLP Takes Position in Henry Schein, Inc. $HSIC - MarketBeat
Did Henry Schein’s (HSIC) Expanded vVARDIS Deal Quietly Recast Its Minimally Invasive Dental Strategy? - simplywall.st
Henry Schein (HSIC) Form 4 details 2,032-share RSU tax surrender by executive - Stock Titan
Henry Schein Expands Partnership with vVARDIS - Zenopa
California Public Employees Retirement System Sells 120,408 Shares of Henry Schein, Inc. $HSIC - MarketBeat
Amundi Has $14.03 Million Stock Holdings in Henry Schein, Inc. $HSIC - MarketBeat
Barclays Begins Coverage on Henry Schein (NASDAQ:HSIC) - MarketBeat
Is Henry Schein’s Streamlined Distribution Strategy Creating Value at Around $74 a Share in 2025? - simplywall.st
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):